Amneal Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
17 May 24 | SellUS$256,106 | Deborah Autor | Individual | 38,000 | US$6.76 | |
11 Aug 23 | SellUS$120,921 | Andrew Boyer | Individual | 29,302 | US$4.13 |
Insider Trading Volume
Insider Buying: AMRX insiders have only sold shares in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 12,314,248 | 3.99% |
General Public | 35,164,207 | 11.4% |
Institutions | 97,506,793 | 31.6% |
Individual Insiders | 163,666,125 | 53% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
53,578,209 | US$385.2m | 0% | no data | |||
30,384,769 | US$218.5m | 0% | no data | |||
26,905,073 | US$193.4m | 0% | no data | |||
25,265,818 | US$181.7m | 0% | no data | |||
21,781,986 | US$156.6m | 0% | no data | |||
13,728,233 | US$98.7m | 0.63% | no data | |||
12,328,767 | US$88.6m | 0% | 0.28% | |||
12,314,248 | US$88.5m | -42.8% | no data | |||
9,541,948 | US$68.6m | 19.3% | 1.31% | |||
9,164,172 | US$65.9m | 3.59% | no data | |||
5,067,483 | US$36.4m | -22% | 0.04% | |||
3,920,975 | US$28.2m | 4.81% | 0.02% | |||
3,642,523 | US$26.2m | 29.1% | no data | |||
2,944,198 | US$21.2m | 5.19% | no data | |||
2,773,050 | US$19.9m | 13.7% | no data | |||
2,619,943 | US$18.8m | 12.2% | 1.84% | |||
2,048,886 | US$14.7m | 6.08% | no data | |||
1,955,290 | US$14.1m | 0% | no data | |||
1,413,297 | US$10.2m | 0% | 5.88% | |||
1,267,184 | US$9.1m | -4.05% | no data | |||
1,230,334 | US$8.8m | -7.46% | no data | |||
1,187,424 | US$8.5m | -15.6% | no data | |||
1,154,700 | US$8.3m | 0% | 0.31% | |||
1,065,600 | US$7.7m | -2.18% | 0.01% | |||
846,826 | US$6.1m | 149% | no data |